197 related articles for article (PubMed ID: 25047305)
1. Pharmacokinetic evaluation of intravenous artesunate in adults with uncomplicated falciparum malaria in Kenya: a phase II study.
Li Q; Remich S; Miller SR; Ogutu B; Otieno W; Melendez V; Teja-Isavadharm P; Weina PJ; Hickman MR; Smith B; Polhemus M
Malar J; 2014 Jul; 13():281. PubMed ID: 25047305
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria.
McGready R; Stepniewska K; Ward SA; Cho T; Gilveray G; Looareesuwan S; White NJ; Nosten F
Eur J Clin Pharmacol; 2006 May; 62(5):367-71. PubMed ID: 16552504
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of chlorproguanil, dapsone, artesunate and their major metabolites in patients during treatment of acute uncomplicated Plasmodium falciparum malaria.
Miller AK; Bandyopadhyay N; Wootton DG; Duparc S; Kirby PL; Winstanley PA; Ward SA
Eur J Clin Pharmacol; 2009 Oct; 65(10):977-87. PubMed ID: 19517101
[TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria.
Newton PN; Barnes KI; Smith PJ; Evans AC; Chierakul W; Ruangveerayuth R; White NJ
Eur J Clin Pharmacol; 2006 Dec; 62(12):1003-9. PubMed ID: 17089111
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic profiles of artesunate after single intravenous doses at 0.5, 1, 2, 4, and 8 mg/kg in healthy volunteers: a phase I study.
Li Q; Cantilena LR; Leary KJ; Saviolakis GA; Miller RS; Melendez V; Weina PJ
Am J Trop Med Hyg; 2009 Oct; 81(4):615-21. PubMed ID: 19815876
[TBL] [Abstract][Full Text] [Related]
6. A pharmacokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated falciparum malaria.
Batty KT; Thu LT; Davis TM; Ilett KF; Mai TX; Hung NC; Tien NP; Powell SM; Thien HV; Binh TQ; Kim NV
Br J Clin Pharmacol; 1998 Feb; 45(2):123-9. PubMed ID: 9491824
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients.
Simpson JA; Agbenyega T; Barnes KI; Di Perri G; Folb P; Gomes M; Krishna S; Krudsood S; Looareesuwan S; Mansor S; McIlleron H; Miller R; Molyneux M; Mwenechanya J; Navaratnam V; Nosten F; Olliaro P; Pang L; Ribeiro I; Tembo M; van Vugt M; Ward S; Weerasuriya K; Win K; White NJ
PLoS Med; 2006 Nov; 3(11):e444. PubMed ID: 17132053
[TBL] [Abstract][Full Text] [Related]
8. Fixed dose artesunate amodiaquine - a phase IIb, randomized comparative trial with non-fixed artesunate amodiaquine.
Ogutu B; Juma E; Obonyo C; Jullien V; Carn G; Vaillant M; Taylor WR; Kiechel JR
Malar J; 2014 Dec; 13():498. PubMed ID: 25515698
[TBL] [Abstract][Full Text] [Related]
9. New fixed-dose artesunate-mefloquine formulation against multidrug-resistant Plasmodium falciparum in adults: a comparative phase IIb safety and pharmacokinetic study with standard-dose nonfixed artesunate plus mefloquine.
Krudsood S; Looareesuwan S; Tangpukdee N; Wilairatana P; Phumratanaprapin W; Leowattana W; Chalermrut K; Ramanathan S; Navaratnam V; Olliaro P; Vaillant M; Kiechel JR; Taylor WR
Antimicrob Agents Chemother; 2010 Sep; 54(9):3730-7. PubMed ID: 20547795
[TBL] [Abstract][Full Text] [Related]
10. Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria.
Gutman J; Green M; Durand S; Rojas OV; Ganguly B; Quezada WM; Utz GC; Slutsker L; Ruebush TK; Bacon DJ
Malar J; 2009 Apr; 8():58. PubMed ID: 19358697
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of intravenous artesunate during severe malaria treatment in Ugandan adults.
Byakika-Kibwika P; Lamorde M; Mayito J; Nabukeera L; Mayanja-Kizza H; Katabira E; Hanpithakpong W; Obua C; Pakker N; Lindegardh N; Tarning J; de Vries PJ; Merry C
Malar J; 2012 Apr; 11():132. PubMed ID: 22540954
[TBL] [Abstract][Full Text] [Related]
12. The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria.
McGready R; Stepniewska K; Edstein MD; Cho T; Gilveray G; Looareesuwan S; White NJ; Nosten F
Eur J Clin Pharmacol; 2003 Oct; 59(7):545-52. PubMed ID: 12955371
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of a new ACT formulation: Artesunate/Amodiaquine (TRIMALACT) following oral administration in African malaria patients.
Sinou V; Malaika LT; Taudon N; Lwango R; Alegre SS; Bertaux L; Sugnaux F; Parzy D; Benakis A
Eur J Drug Metab Pharmacokinet; 2009; 34(3-4):133-42. PubMed ID: 20166428
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics and pharmacodynamics of the artesunate-mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African children.
Guidi M; Mercier T; Aouri M; Decosterd LA; Csajka C; Ogutu B; Carn G; Kiechel JR
Malar J; 2019 Apr; 18(1):139. PubMed ID: 30999915
[TBL] [Abstract][Full Text] [Related]
15. Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria.
Blanshard A; Hine P
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD004529. PubMed ID: 33459345
[TBL] [Abstract][Full Text] [Related]
16. Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration.
Morris CA; Duparc S; Borghini-Fuhrer I; Jung D; Shin CS; Fleckenstein L
Malar J; 2011 Sep; 10():263. PubMed ID: 21914160
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic profiles of artesunate following multiple intravenous doses of 2, 4, and 8 mg/kg in healthy volunteers: phase 1b study.
Miller RS; Li Q; Cantilena LR; Leary KJ; Saviolakis GA; Melendez V; Smith B; Weina PJ
Malar J; 2012 Aug; 11():255. PubMed ID: 22853818
[TBL] [Abstract][Full Text] [Related]
18. Validation and pharmacokinetic application of a high-performance liquid chromatographic technique for determining the concentrations of amodiaquine and its metabolite in plasma of patients treated with oral fixed-dose amodiaquine-artesunate combination in areas of malaria endemicity.
Adedeji ON; Bolaji OO; Falade CO; Osonuga OA; Ademowo OG
Antimicrob Agents Chemother; 2015 Sep; 59(9):5114-22. PubMed ID: 25896711
[TBL] [Abstract][Full Text] [Related]
19. Disposition of artesunate and dihydroartemisinin after administration of artesunate suppositories in children from Papua New Guinea with uncomplicated malaria.
Karunajeewa HA; Ilett KF; Dufall K; Kemiki A; Bockarie M; Alpers MP; Barrett PH; Vicini P; Davis TM
Antimicrob Agents Chemother; 2004 Aug; 48(8):2966-72. PubMed ID: 15273107
[TBL] [Abstract][Full Text] [Related]
20. Comparative pharmacokinetics and effect kinetics of orally administered artesunate in healthy volunteers and patients with uncomplicated falciparum malaria.
Teja-Isavadharm P; Watt G; Eamsila C; Jongsakul K; Li Q; Keeratithakul G; Sirisopana N; Luesutthiviboon L; Brewer TG; Kyle DE
Am J Trop Med Hyg; 2001 Dec; 65(6):717-21. PubMed ID: 11791963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
